Harrison J L, Turek B J, Brown D C, Bradley C, Callahan Clark J
Department of Clinical Studies, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA.
Department of Pathobiology, School of Veterinary Medicine, University of Pennsylvania, Philadelphia, PA.
J Vet Intern Med. 2018 Jan;32(1):172-180. doi: 10.1111/jvim.14866. Epub 2017 Nov 13.
Cholangitis in dogs appears to be more common than previously thought, but understanding of the disease remains incomplete.
To describe a population of dogs with cholangitis or cholangiohepatitis.
Fifty-four client-owned dogs with cholangitis or cholangiohepatitis.
Medical records of dogs with cholangitis or cholangiohepatitis confirmed by histopathology between January 2004 and December 2014 were identified using a computer-based search and retrospectively reviewed.
Clinical signs included vomiting (72.2%), lethargy (70.4%), and inappetence (64.8%). Most dogs (49/50) had increased liver enzyme activities, hyperbilirubinemia (32/50), and hypercholesterolemia (24/43). Ultrasonographic abnormalities of the hepatobiliary system were seen in 84% of cases. On histopathology, 53 of 54 affected dogs had neutrophilic cholangitis (NC) or cholangiohepatitis, whereas 1 dog had lymphocytic cholangitis. Most cases (42/54) were chronic. Evidence of concurrent biliary disease (46.2%) and biliary tract obstruction (42.6%) was common. Seventeen of 36 biliary and 11 of 25 liver cultures were positive for bacterial growth; Escherichia coli and Enterococcus spp. were most common. Median patient survival was 671 days (95% confidence interval [CI]: 114-1,426). On Cox regression, dogs that did not have a cholecystectomy performed had a 2.1 greater hazard for death (P = 0.037; 95% CI: 1.0-4.3) compared to cholecystectomized dogs. Dogs >13 years old had a 5.0 greater hazard for death (P = 0.001; 95% CI: 1.9-13.2) compared to younger dogs.
Chronic NC or cholangiohepatitis was most common. Cholecystitis and biliary tract obstruction often occurred in conjunction with cholangitis. Cholecystectomized dogs had decreased risk of death; thus, cholecystectomy may improve patient outcome.
犬胆管炎似乎比以前认为的更为常见,但对该疾病的了解仍不完整。
描述患有胆管炎或胆管肝炎的犬群。
54只客户拥有的患有胆管炎或胆管肝炎的犬。
通过基于计算机的搜索确定2004年1月至2014年12月间经组织病理学确诊为胆管炎或胆管肝炎的犬的病历,并进行回顾性审查。
临床症状包括呕吐(72.2%)、嗜睡(70.4%)和食欲不振(64.8%)。大多数犬(49/50)肝酶活性升高、高胆红素血症(32/50)和高胆固醇血症(24/43)。84%的病例可见肝胆系统超声异常。组织病理学检查显示,54只患病犬中有53只患有中性粒细胞性胆管炎(NC)或胆管肝炎,而1只患有淋巴细胞性胆管炎。大多数病例(42/54)为慢性。并发胆道疾病(46.2%)和胆道梗阻(42.6%)的证据很常见。36份胆汁培养物中有17份和25份肝脏培养物中有11份细菌生长呈阳性;大肠杆菌和肠球菌属最为常见。患者中位生存期为671天(95%置信区间[CI]:114 - 1426)。在Cox回归分析中,未进行胆囊切除术的犬死亡风险比接受胆囊切除术的犬高2.1倍(P = 0.037;95% CI:1.0 - 4.3)。13岁以上的犬死亡风险比年轻犬高5.0倍(P = 0.001;95% CI:1.9 - 13.2)。
慢性NC或胆管肝炎最为常见。胆囊炎和胆道梗阻常与胆管炎同时发生。接受胆囊切除术的犬死亡风险降低;因此,胆囊切除术可能改善患者预后。